Hematology
3 stories
-
healthCAR T Therapy: 4-1BB Design Dominates Leukemia Treatment
New meta-analysis reveals 4-1BB CAR T constructs offer superior efficacy and safety for relapsed B-cell acute lymphoblastic leukemia.
-
healthUltra-Refractory Myeloma: Genomic Complexity and Dire Outcomes
New data reveals extreme genomic complexity in hepta-refractory multiple myeloma, with limited survival and urgent need for novel therapies.
-
healthR-CHOP Retreatment Shows Promise for Late Relapse Lymphoma
New research indicates that re-treating diffuse large B-cell lymphoma patients with R-CHOP can lead to durable responses and improved outcomes, particularly for those with late relapses.